project id: TCGA-STAD; case submitter id: TCGA-VQ-A927; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.26; rna integrity number: 7.1; age at index: 81; days to birth: -29676; days to death: 200; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1932; year of death: 2013; age at diagnosis: 29676; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C16.2; last known disease status: not reported; morphology: 8145/3; primary diagnosis: Carcinoma, diffuse type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Body of stomach; synchronous malignancy: No; tissue or organ of origin: Body of stomach; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 159; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-VQ-A927-01A-12; percent lymphocyte infiltration: 80.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 25.0; percent stromal cells: 25.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0;